DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 81 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 0.02 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $5,910,000 | -66.5% | 103,565 | -69.9% | 0.52% | -69.7% |
| Q3 2020 | $17,645,000 | +4.4% | 343,965 | +21.6% | 1.73% | +9.1% |
| Q2 2020 | $16,899,000 | +243.5% | 282,965 | +136.8% | 1.59% | +158.4% |
| Q1 2020 | $4,920,000 | +84.3% | 119,500 | +3.9% | 0.62% | +152.0% |
| Q1 2019 | $2,670,000 | +10.6% | 115,033 | 0.0% | 0.24% | -10.3% |
| Q4 2018 | $2,415,000 | -43.3% | 115,033 | +4.5% | 0.27% | -44.4% |
| Q3 2018 | $4,260,000 | +16.4% | 110,033 | +18.3% | 0.49% | -3.2% |
| Q2 2018 | $3,661,000 | +347.0% | 93,031 | +127.8% | 0.50% | +307.3% |
| Q1 2018 | $819,000 | -83.6% | 40,846 | -81.8% | 0.12% | -78.9% |
| Q4 2017 | $5,008,000 | +251.7% | 224,154 | +198.9% | 0.59% | +189.7% |
| Q3 2017 | $1,424,000 | – | 75,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 4,104,140 | $93,041,000 | 43.52% |
| SV Health Investors, LLC | 1,716,303 | $38,909,000 | 20.55% |
| PURA VIDA INVESTMENTS, LLC | 68,154 | $1,545,000 | 0.65% |
| Redmile Group, LLC | 683,880 | $14,658,000 | 0.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 77,000 | $1,746,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,154 | $5,008,000 | 0.59% |
| EMERALD ADVISERS, LLC | 482,626 | $10,941,000 | 0.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 416,342 | $9,438,000 | 0.38% |
| Orbimed Advisors | 1,176,070 | $26,662,000 | 0.34% |
| VIKING GLOBAL INVESTORS LP | 2,394,625 | $54,286,000 | 0.33% |